Short- and long-term results after multivessel stenting in diabetic patients
Roxana Mehran, MD, FACC*,
George D. Dangas, MD, PhD, FACC*,*,
Yoshio Kobayashi, MD, FACC*,
Alexandra J. Lansky, MD, FACC*,
Gary S. Mintz, MD, FACC*,
Eve D. Aymong, MD, MSc*,
Martin Fahy, MSc*,
Jeffrey W. Moses, MD, FACC,,
Gregg W. Stone, MD, FACC* and
Martin B. Leon, MD, FACC*
* Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
View larger version (19K):
[in a new window]
|
Figure 1 Actuarial survival curves after multivessel stenting. Lower survival is observed in patients with diabetes mellitus (DM) treated with either oral agents or insulin, compared with non-diabetic patients.
|
|
View larger version (21K):
[in a new window]
|
Figure 2 Actuarial event-free survival curves after multivessel stenting. Lower event-free survival is observed in patients with diabetes mellitus (DM) treated with either oral agents or insulin.
|
|
|
